SHARE-BASED PAYMENT - Fair value assumptions of Bonus in performance (Details)	12 Months Ended
Jun. 30, 2022 USD ($) $ / shares
Bonus Performance Award At Exercise Price 10.5 US Dollar [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Stock price at the grant date	$ 5.42
Exercise Price	$ 10.5
Weighted average expected volatility	24.78%
Dividend rate	0.00%
Weighted average risk-free interest rate	1.52%
Weighted average expected life	2 years 7 months 17 days
Weighted average fair value of stock at measurement date \| $	$ 0.479
Bonus Performance Award At Exercise Price 21.0 US Dollar [Member]
Disclosure of terms and conditions of share-based payment arrangement [line items]
Stock price at the grant date	$ 5.42
Exercise Price	$ 21.0
Weighted average expected volatility	24.78%
Dividend rate	0.00%
Weighted average risk-free interest rate	1.52%
Weighted average expected life	2 years 7 months 17 days
Weighted average fair value of stock at measurement date \| $	$ 0.005

The exercise price of other equity instruments granted.

No definition available.

Name:	biox_ExercisePriceOtherEquityInstrumentsGranted
Namespace Prefix:	biox_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The percentage of an expected dividend used to calculate the fair value of other equity instruments granted.

+ References

No definition available.

+ Details

Name:	biox_ExpectedDividendAsPercentageOtherEquityInstrumentsGranted
Namespace Prefix:	biox_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The price of each stock under other equity instruments at the grant date.

+ References

No definition available.

+ Details

Name:	biox_StockPriceAtGrantDate
Namespace Prefix:	biox_
Data Type:	dtr-types:perShareItemType
Balance Type:	na
Period Type:	duration

- Definition

The weighted average expected life of other equity instruments granted.

+ References

No definition available.

+ Details

Name:	biox_WeightedAverageExpectedLifeOtherEquityInstrumentsGranted
Namespace Prefix:	biox_
Data Type:	xbrli:durationItemType
Balance Type:	na
Period Type:	duration

- Definition

The weighted average expected volatility of the share price used to calculate the fair value of other equity instruments granted. Expected volatility is a measure of the amount by which a price is expected to fluctuate during a period. The measure of volatility used in option pricing models is the annualised standard deviation of the continuously compounded rates of return on the share over a period of time.

+ References

No definition available.

+ Details

Name:	biox_WeightedAverageExpectedVolatilityOtherEquityInstrumentsGranted
Namespace Prefix:	biox_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

The percentage of weighted average risk-free interest rate used to calculate the fair value of other equity instruments granted.

+ References

No definition available.

+ Details

Name:	biox_WeightedAverageRiskFreeInterestRateOtherEquityInstrumentsGranted
Namespace Prefix:	biox_
Data Type:	dtr-types:percentItemType
Balance Type:	na
Period Type:	duration

- Definition

Line items represent concepts included in a table. These concepts are used to disclose reportable information associated with members defined in one or many axes of the table.

+ References

No definition available.

+ Details

Name:	ifrs-full_DisclosureOfTermsAndConditionsOfSharebasedPaymentArrangementLineItems
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

- Definition

The weighted average fair value at the measurement date of granted equity instruments other than share options. [Refer: Weighted average [member]]

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Name IFRS
-Number 2
-IssueDate 2022-03-24
-Paragraph 47
-Subparagraph b
-URI https://taxonomy.ifrs.org/xifrs-link?type=IFRS&num=2&code=ifrs-tx-2022-en-r&anchor=para_47_b&doctype=Standard
-URIDate 2022-03-24

+ Details

Name:	ifrs-full_WeightedAverageFairValueAtMeasurementDateOtherEquityInstrumentsGranted
Namespace Prefix:	ifrs-full_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=biox_BonusPerformanceAwardAtExercisePrice10.5UsDollarMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

- Details

Name:	ifrs-full_TypesOfSharebasedPaymentArrangementsAxis=biox_BonusPerformanceAwardAtExercisePrice21.0UsDollarMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: